Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review
Highlights Studies showed that the risk of developing Covid-19 is more worrying in people with immunocompromised conditions, such as inflammatory bowel disease (IBD). On the other hand, no definitive treatment has been identified for it and the best way to control it is wide spread vaccination. The...
Main Authors: | Elham Tabesh, Maryam Soheilipour, Mohammad Rezaeisadrabadi, Elahe Zare-Farashbandi, Razieh Sadat Mousavi-Roknabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02460-1 |
Similar Items
-
Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
by: Martyna Więcek, et al.
Published: (2022-10-01) -
Review of the safety with biologics in inflammatory bowel disease
by: Andrea Pascual, et al.
Published: (2022-07-01) -
Helminth Lessons in Inflammatory Bowel Diseases (IBD)
by: Tyler Atagozli, et al.
Published: (2023-04-01) -
Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)—A Narrative Review
by: Corinne Légeret, et al.
Published: (2022-04-01) -
A MEDICAL AND NEUROPSYCHIATRIC MANAGEMENT SURVEY IN A BRAZILIAN COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
by: Antônio Miguel Furtado LEITÃO, et al.
Published: (2024-03-01)